3Tsuehimochi N, Takuma T, Shimono N, et al. Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa [J]. J Infect Chemother, 2008,14(2) :99-104.
7Ubukata K, Chiba N, Kobayashi R, et al. Comparison of in vitro activity of biapenem with other antimicrobial agents against clinical isolates of Pseudomonas aeruginosa [ J ]. Chemother Jpn, 2002, 50(1) : 1-10.
8Hikida M, Kawashima K, Yoshida M, et al. Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex [ J ]. J Antimicrob Chemother, 1992, 30: 129-34.
7Robert A,Ahmed R. Similarities and differences in CD4 and CDs effector and memory T cell generation[J].{H}Nature Immunology,2003,(09):563-581.
8Choudry K,Brooke RC,Farrar W. The effect of an iron chelating agent on protoporphyrin Ⅸ levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy[J].{H}British Journal of Dermatology,2003,(01):124.
